Hangzhou, China

Li'na Zhu

This inventor holds 1 USPTO granted patent. Top assignee: Zhejiang Doer Biologics Co., Ltd.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Li'na Zhu. Retrieved from https://idiyas.com/inventor/li-na-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Li'na Zhu in the Field of Biology

Introduction

Li'na Zhu is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of biology, particularly in the development of heavy-chain antibodies. His work focuses on innovative solutions that have the potential to impact medical science and treatment.

Latest Patents

Li'na Zhu holds a patent for "Heavy-chain antibodies (VHHs) against claudin 18A2 and use thereof." This patent relates to an anti-CLD18A2 VHH, which includes a complementarity determining region (CDR) with specific amino acid sequences. The anti-CLD18A2 VHH can specifically bind to the epitope on CLD18A2, demonstrating good specificity and affinity, along with a noticeable tumor suppression effect. He has 1 patent to his name.

Career Highlights

Li'na Zhu is associated with Zhejiang Doer Biologics Co., Ltd., where he continues to advance his research and innovations. His work is pivotal in the development of therapeutic solutions that target specific biological markers.

Collaborations

Li'na Zhu collaborates with notable colleagues, including Gaofeng Yao and Yali Lu. Their combined expertise enhances the research and development efforts within their organization.

Conclusion

Li'na Zhu's contributions to the field of biology through his innovative patents and collaborations highlight his role as a key inventor in advancing medical science. His work continues to pave the way for future breakthroughs in treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…